痛风的西医治疗进展
摘要
关键词
全文:
PDF参考
[1]Dalbeth N, Merriman T R, Stamp L K. Gout[J]. Lancet, 2016,388(10055):2039-2052. [2]Kuo C F, Grainge M J, Zhang W, et al. Global epidemiology of gout: prevalence, incidence and risk factors[J]. Nat Rev Rheumatol, 2015,11(11):649-662. [3]杨丽华, 刘晓丽, 蒋雅琼, 等. 我国痛风的患病率及危险因素[J]. 医学研究杂志, 2019,48(12):4-6. [4]Khanna D, Fitzgerald J D, Khanna P P, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia[J]. Arthritis Care Res (Hoboken), 2012,64(10):1431- 1446. [5]Terkeltaub R A, Furst D E, Bennett K, et al. High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebocontrolled,parallel-group, dose-comparison colchicine study[J]. Arthritis Rheum, 2010,62(4):1060-1068. [6]Khanna D, Fitzgerald J D, Khanna P P, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia[J]. Arthritis Care Res (Hoboken), 2012,64(10):1431-1446. [7]曾小峰, 陈耀龙. 2016 中国痛风诊疗指南[J]. 浙江医学, 2017,39(21):1823-1832.
DOI: http://dx.doi.org/10.12361/2661-3603-04-05-87606
Refbacks
- 当前没有refback。